Immunovant, Inc. (IMVT) Misses Q4 EPS by 13c
Get Alerts IMVT Hot Sheet
Join SI Premium – FREE
Immunovant, Inc. (NASDAQ: IMVT) reported Q4 EPS of ($0.73), $0.13 worse than the analyst estimate of ($0.60).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cencora says Walgreens volumes shift, reaffirms guidance, shares sink
- Nebius soars on second quarter revenue beat
- L3Harris opens $6M naval training facility in Providence, R.I.
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share